QNTM
Quantum Biopharma Subordinate Voting SharesANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
Current thesis
The bull case is that Lucid-MS remains the core value driver: the company has already reported an IND submission milestone, lined up Phase 2 infrastructure, and improved liquidity enough to reduce near-term financing stress. If trial execution stays on track, the equity can continue to trade on pipeline optionality rather than immediate dilution risk.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -6.1.
What can break
Clinical execution risk remains high: Lucid-MS still needs successful regulatory follow-through and Phase 2 execution before the pipeline can de-risk.
Momentum
94
Value
42
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.75 · Bull $9.75 · Bear $2.50
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $45.00
Why
Momentum94 · Δ7d -6.1
Value42 · Δ7d +0.0
Sentiment64 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
94
34% active weight
Current posture
7d trendSoftening
Δ7d
-6.1
Δ21d
+69.2
Value
42
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.2
Sentiment
64
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 94.0 / Value 41.9 / Sentiment 64.5
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$29.91M
Beta
0.79
Shares Out
3.84M
P/E (TTM) · Derived
-0.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-2.50
Rev YoY
-
EPS YoY
+68.0%
Gross Margin
-
Op Margin
-
Net Debt
-$6.37M
Current Ratio
1.41
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology